| CASE REPORT |
|
| Year : 2022 | Volume
: 12
| Issue : 2 | Page : 79-81 |
|
|
Post-COVID-19 sequela: Massive tubercular pericardial effusion in immunocompromised patient
G Anand Kumar, Lakhan Parajiya, SP Avinash Pandi, Vishalkumar Amrutbhai Patel
Department of General Medicine, Vinayaka Mission's Kirupananda Variyar Medical College and Hospitals, Salem, Tamil Nadu, India
Correspondence Address:
Dr. Lakhan Parajiya
PG, Boys Hostel, Vinayaka Mission's Kirupananda Variyar Medical College and Hospital, Salem - 636 308, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jicc.jicc_34_21
|
|
|
Long-term sequelae following COVID-19 infection are not well established. Hence, COVID-19 sequelae are been studied extensively as cases are being followed up to reduce avoidable prolonged morbidity and mortality in the country. COVID-19 and currently available drugs for treatment are both reasons for a change in immune status of patients leading to reactivation or increase the chance of infection of common diseases like tuberculosis (TB), particularly in India. A case of post-COVID-19 disease (2 months back) presented with breathlessness and chest pain. On history, workup, and evaluation, the case was diagnosed with massive tubercular pericardial effusion suggesting reactivation of latent TB in a post-COVID-19 disease. Due to COVID-19 disease itself and possible immunomodulatory drugs used for treatment, reactivation of latent TB has to be considered in post-COIVD-19 disease with nonspecific presentation and unexplained prolonged clinical course of the disease. This case highlights the need of further follow-up of COVID-19 patients to understand the effects of disease on the immune system and the possibilities of opportunistic infections, especially after this second wave of COVID-19.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
